Beijing Tri Prime Gene Pharmaceutical Co (BJSE:837344) Total Stockholders Equity : ¥608.6 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Beijing Tri Prime Gene Pharmaceutical Co Total Stockholders Equity?

Beijing Tri Prime Gene Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ¥608.6 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Beijing Tri Prime Gene Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2025 was ¥5.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Beijing Tri Prime Gene Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.85.

Beijing Tri Prime Gene Pharmaceutical Co Total Stockholders Equity Historical Data

The historical data trend for Beijing Tri Prime Gene Pharmaceutical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Tri Prime Gene Pharmaceutical Co Total Stockholders Equity Chart

Beijing Tri Prime Gene Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

529.31

543.17

574.81

610.94

620.82

Beijing Tri Prime Gene Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															613.68	612.32	610.50	620.82	608.57

Beijing Tri Prime Gene Pharmaceutical Co (BJSE:837344) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Beijing Tri Prime Gene Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(608.57	-	0)	/	121.810
	=	5.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Beijing Tri Prime Gene Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(82.414	+	437)	/	608.57
	=	0.85

Beijing Tri Prime Gene Pharmaceutical Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Beijing Tri Prime Gene Pharmaceutical Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Tri Prime Gene Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Tri Prime Gene Pharmaceutical Co Ltd (BJSE:837344) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Jinyuan Road, Building 4, Daxing Economic Development Zone, Daxing District, Beijing, CHN, 102600

Website

http://www.triprime.com

Beijing Tri Prime Gene Pharmaceutical Co Ltd is mainly engaged in the research, development, production, and sales of medical biotechnology products including genetic engineering drugs, genetic engineering vaccines, and diagnostic reagents, and engaged in related technical trade and technical consulting services. Its product line comprises Yundex Spray, Yundex Eye Drops, Yundexol Powder Injection, Yundexol Water Injection.

Beijing Tri Prime Gene Pharmaceutical Co Headlines

No Headlines